Prot #NU UM20I04: Phase 1/2 Trial to Evaluate Cabozantinib in Patients with Advanced Hepatocellular Carcinoma with Child Pugh Class B Cirrhosis after First-Line Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date9/11/206/28/25

Funding

  • University of Michigan (Prot #NU UM20I04 // Prot #NU UM20I04)
  • Exelixis Inc. (Prot #NU UM20I04 // Prot #NU UM20I04)